Photography by Alex Welsh

One Inventor’s Race to Manage His Parkinson’s Disease With an App

Ray Finucane was dubbed an engineering ‘wizard.’ Managing his own brain is his toughest challenge yet.

Peter Andrey Smith
OneZero
Published in
14 min readMay 22, 2019

--

RRay Finucane, a retired mechanical engineer, has flown supersonic jets in Florida, built a 33-acre island of ice in the Arctic Ocean, and worked on hydrogen gas guns that could catapult satellites into orbit. His colleagues used to call him “the wizard.” Now, at 75 years old, Finucane has turned his attention inward, on a complex system that’s proven even more bewildering: the flow of dopamine within his own brain.

Finucane has Parkinson’s disease, a condition that occurs when cells in the substantia nigra, a region in the midbrain, deteriorate and die. These cells produce dopamine, a chemical messenger that is essential for normal muscle movement. To replenish dopamine levels, doctors prescribe levodopa, a drug that remains the gold standard for treatment despite the fact that it is now more than a half -century old. But because there’s no practical way to monitor the concentration of dopamine in the body, it’s difficult to perfectly tailor the dosing of levodopa to an individual patient’s needs. Too much levodopa can mean overfilling the brain’s tank with dopamine; too little can mean running out of steam. While doctors do their best…

--

--

OneZero
OneZero

Published in OneZero

OneZero is a former publication from Medium about the impact of technology on people and the future. Currently inactive and not taking submissions.

Responses (14)